PARTOW KEBRIAEI to Angiogenesis Inhibitors
This is a "connection" page, showing publications PARTOW KEBRIAEI has written about Angiogenesis Inhibitors.
Connection Strength
0.093
-
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma. Cancer. 2016 Dec 15; 122(24):3831-3837.
Score: 0.081
-
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. Biol Blood Marrow Transplant. 2009 Jun; 15(6):718-23.
Score: 0.012